DaVita Inc.(DVA) Stock Research - Grey Stern Research
Loading...

DaVita Inc. (DVA) Stock Analysis

$140.03 (-1.04%)

DVA Financial Performance


Use the table below to view DaVita Inc.'s financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q4 - 2024

Metric Value Ranking among Peers
Price $140.03 -
52 Week Low $125.97 -
52 Week High $179.60 -
Market Cap $11.2 Billion 4/13
Gross Margin 100% 1/13
Profit Margin 8% 2/13
EBITDA margin 22% 1/13
Q4 - 2024 Revenue $3.3 Billion 4/13
Q4 - 2024 Earnings $259.3 Million 4/13
Q4 - 2024 Free Cash Flow $377.0 Million 3/13
Trailing 4 Quarters Revenue $12.8 Billion 4/13
Trailing 4 Quarters Earnings $936.3 Million 4/13
Quarterly Earnings Growth 72% 3/13
Annual Earnings Growth 5% 8/13
Quarterly Revenue Growth 5% 8/13
Annual Revenue Growth 2% 10/13
Cash On Hand $794.9 Million 3/13
Short Term Debt $0 12/13
Long Term Debt $11.4 Billion 2/13

DaVita Inc. Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare DaVita Inc.'s metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE 11.96 7/13
PS 0.87 7/13
PB 5.36 1/13
PC 14.09 8/13
Liabilities to Equity 125.44 1/13
ROA 0.05 7/13
ROE 7.73 1/13
Current Ratio 1.14 11/13
Quick Ratio 0.06 6/13
Long Term Debt to Equity 94.00 1/13
Debt to Equity 94.00 1/13
Burn Rate 4.05 6/13
Cash to Cap 0.07 6/13
CCR 1.45 2/13
EV to EBITDA 29.99 7/13
EV to Revenue 1.70 4/13

Company Details

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

CEO: Mr. Javier Rodriguez

Website: https://www.davita.com

Address: 2000 16th St Denver, COLORADO

Exchange: New York Stock Exchange

Industry: Medical Care Facilities

DaVita Inc. Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to DaVita Inc.. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
Community Health Systems, Inc. CYH $338.1 Million
Tenet Healthcare Corporation THC $11.5 Billion
HCA Healthcare, Inc. HCA $82.5 Billion
AMN Healthcare Services, Inc. AMN $706.3 Million
Universal Health Services, Inc. UHS $11.4 Billion
Acadia Healthcare Company, Inc. ACHC $2.2 Billion
Surgery Partners, Inc. SGRY $2.7 Billion
Encompass Health Corporation EHC $10.4 Billion
Amedisys, Inc. AMED $3.0 Billion
U.S. Physical Therapy, Inc. USPH $1.0 Billion
The Ensign Group, Inc. ENSG $7.4 Billion
Option Care Health, Inc. OPCH $5.3 Billion
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
DVA Income Statements
Quarter Year Revenue Earnings
Q4 2024 $ 3.3 Billion $259.3 Million
Q3 2024 $ 3.3 Billion $214.7 Million
Q2 2024 $ 3.2 Billion $222.7 Million
Q1 2024 $ 3.1 Billion $239.6 Million
Q4 2023 $ 3.1 Billion $150.7 Million
Q3 2023 $ 3.1 Billion $246.6 Million
Q2 2023 $ 3.0 Billion $178.7 Million
Q1 2023 $ 2.9 Billion $170.7 Million

View All

DVA Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q4 2024 $794.9 Million $17.3 Billion $11.4 Billion $1.8 Billion
Q3 2024 $1.1 Billion $17.5 Billion $9.6 Billion $2.2 Billion
Q2 2024 $416.5 Million $17.9 Billion $10.7 Billion $2.2 Billion
Q1 2024 $345.1 Million $17.4 Billion $11.8 Billion $2.6 Billion
Q4 2023 $464.6 Million $17.6 Billion $11.1 Billion $2.7 Billion
Q3 2023 $449.5 Million $16.9 Billion $11.1 Billion $2.8 Billion
Q2 2023 $327.4 Million $17.0 Billion $11.5 Billion $1.0 Billion
Q1 2023 $317.1 Million $16.7 Billion $11.5 Billion $825.5 Million

View All

DVA Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q4 2024 $377.0 Million -$170.7 Million -$278.8 Million
Q3 2024 $671.4 Million -$139.0 Million $655.4 Million
Q2 2024 $677.8 Million -$124.7 Million $72.5 Million
Q1 2024 -$255.9 Million -$121.0 Million -$33.9 Million
Q4 2023 $327.8 Million -$159.0 Million -$80.5 Million
Q3 2023 $524.4 Million -$136.8 Million $123.0 Million
Q2 2023 $325.6 Million -$124.5 Million $10.8 Million
Q1 2023 $314.9 Million -$147.7 Million $72.4 Million

View All